Modern methods of pathogenetic therapy of multiple sclerosis
In recent years there has been significant progress in the treatment of multiple sclerosis (MS). The article reviews current approaches to the pathogenetic treatment of multiple sclerosis. Authors consider the mechanism of action of drugs modulating disease course. The treatment regimens of the MS with glucocorticoids, interferon ?, glatiramere acetate, mitoksantron, natalizumab are presented. It is emphasized that the management of patients with MS requires an individual approach with the involvement of many specialists in various medical fields.

Keywords: natalizumab, mitoksantron, glatiramere acetate, interferon ?, methylprednisolone, multiple sclerosis